Capitol Health Limited provides diagnostic imaging and related services to the healthcare market in Australia.
Capitol Health Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.41|
|52 Week High||AU$0.23|
|52 Week Low||AU$0.42|
|1 Month Change||6.58%|
|3 Month Change||17.39%|
|1 Year Change||55.77%|
|3 Year Change||39.66%|
|5 Year Change||211.54%|
|Change since IPO||52.83%|
Recent News & Updates
Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?
Capitol Health Limited ( ASX:CAJ ), might not be a large cap stock, but it led the ASX gainers with a relatively large...
Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Capitol Health's (ASX:CAJ) stock is up by a considerable 22% over the past three months. We wonder if and what role the...
|CAJ||AU Healthcare||AU Market|
Return vs Industry: CAJ exceeded the Australian Healthcare industry which returned 23.6% over the past year.
Return vs Market: CAJ exceeded the Australian Market which returned 27% over the past year.
Stable Share Price: CAJ is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: CAJ's weekly volatility (6%) has been stable over the past year.
About the Company
Capitol Health Limited provides diagnostic imaging and related services to the healthcare market in Australia. The company owns and operates clinics in Victoria, Tasmania, South Australia, and Western Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy.
Capitol Health Fundamentals Summary
|CAJ fundamental statistics|
Is CAJ overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CAJ income statement (TTM)|
|Cost of Revenue||AU$131.59m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.012|
|Net Profit Margin||6.70%|
How did CAJ perform over the long term?See historical performance and comparison
2.5%Current Dividend Yield
Does CAJ pay a reliable dividends?See CAJ dividend history and benchmarks
|Capitol Health dividend dates|
|Ex Dividend Date||Sep 23 2021|
|Dividend Pay Date||Oct 22 2021|
|Days until Ex dividend||4 days|
|Days until Dividend pay date||33 days|
Does CAJ pay a reliable dividends?See CAJ dividend history and benchmarks
Is Capitol Health undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CAJ (A$0.41) is trading above our estimate of fair value (A$0.28)
Significantly Below Fair Value: CAJ is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CAJ is poor value based on its PE Ratio (35.2x) compared to the Australian Healthcare industry average (26.5x).
PE vs Market: CAJ is poor value based on its PE Ratio (35.2x) compared to the Australian market (18.7x).
Price to Earnings Growth Ratio
PEG Ratio: CAJ is poor value based on its PEG Ratio (2.5x)
Price to Book Ratio
PB vs Industry: CAJ is overvalued based on its PB Ratio (2.9x) compared to the AU Healthcare industry average (2.4x).
How is Capitol Health forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CAJ's forecast earnings growth (14.2% per year) is above the savings rate (1.9%).
Earnings vs Market: CAJ's earnings (14.2% per year) are forecast to grow faster than the Australian market (11.5% per year).
High Growth Earnings: CAJ's earnings are forecast to grow, but not significantly.
Revenue vs Market: CAJ's revenue (6.3% per year) is forecast to grow faster than the Australian market (5.3% per year).
High Growth Revenue: CAJ's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CAJ's Return on Equity is forecast to be low in 3 years time (12.4%).
How has Capitol Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CAJ has a large one-off gain of A$4.6M impacting its June 30 2021 financial results.
Growing Profit Margin: CAJ's current net profit margins (6.7%) are higher than last year (0.6%).
Past Earnings Growth Analysis
Earnings Trend: CAJ's earnings have grown significantly by 30.2% per year over the past 5 years.
Accelerating Growth: CAJ's earnings growth over the past year (1277.9%) exceeds its 5-year average (30.2% per year).
Earnings vs Industry: CAJ earnings growth over the past year (1277.9%) exceeded the Healthcare industry 61.3%.
Return on Equity
High ROE: CAJ's Return on Equity (8.2%) is considered low.
How is Capitol Health's financial position?
Financial Position Analysis
Short Term Liabilities: CAJ's short term assets (A$28.3M) do not cover its short term liabilities (A$37.6M).
Long Term Liabilities: CAJ's short term assets (A$28.3M) do not cover its long term liabilities (A$96.1M).
Debt to Equity History and Analysis
Debt Level: CAJ's debt to equity ratio (19.9%) is considered satisfactory.
Reducing Debt: CAJ's debt to equity ratio has reduced from 115.2% to 19.9% over the past 5 years.
Debt Coverage: CAJ's debt is well covered by operating cash flow (141%).
Interest Coverage: CAJ's interest payments on its debt are well covered by EBIT (6.1x coverage).
What is Capitol Health current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: CAJ's dividend (2.47%) is higher than the bottom 25% of dividend payers in the Australian market (2.3%).
High Dividend: CAJ's dividend (2.47%) is low compared to the top 25% of dividend payers in the Australian market (5.41%).
Stability and Growth of Payments
Stable Dividend: CAJ's dividend payments have been volatile in the past 10 years.
Growing Dividend: CAJ's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (85.6%), CAJ's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CAJ's dividends in 3 years are forecast to be covered by earnings (76.2% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Justin Samuel Walter, MPH (JCU) has been the Chief Executive Officer, Managing Director and a Director at Capitol Health Limited since July 1, 2019. He was the Chief Executive Officer of Zenitas Health...
CEO Compensation Analysis
Compensation vs Market: Justin's total compensation ($USD1.11M) is above average for companies of similar size in the Australian market ($USD722.58K).
Compensation vs Earnings: Justin's compensation has been consistent with company performance over the past year.
Experienced Management: CAJ's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Experienced Board: CAJ's board of directors are considered experienced (4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Capitol Health Limited's employee growth, exchange listings and data sources
- Name: Capitol Health Limited
- Ticker: CAJ
- Exchange: ASX
- Founded: 2005
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: AU$419.154m
- Shares outstanding: 1.03b
- Website: https://www.capitolhealth.com.au
- Capitol Health Limited
- 288 Victoria Parade
- Level 2
- East Melbourne
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/18 08:03|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.